Universal Ibogaine Inc. Stock price Toronto S.E.

Equities

IBO

CA69379R1082

Healthcare Facilities & Services

End-of-day quote Toronto S.E. 06:00:00 2024-02-04 pm EST 5-day change 1st Jan Change
0.01 CAD -33.33% Intraday chart for Universal Ibogaine Inc. -33.33% +100.00%
Sales 2022 1.07 1.45 Sales 2023 1.03 1.4 Capitalization 2.87M 3.89M
Net income 2022 -10M -13.56M Net income 2023 -2M -2.71M EV / Sales 2022 8,069,982 x
Net Debt 2022 1.01M 1.37M Net Debt 2023 2.46M 3.34M EV / Sales 2023 5,181,017 x
P/E ratio 2022
-0.67 x
P/E ratio 2023
-1.2 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is focused on developing a network of addiction treatment clinics and undertake a planned clinical trial for research into the use of ibogaine for addiction treatment. Ibogaine is a naturally-occurring molecule derived from the root bark of the iboga tree and other plants. Ibogaine is a neuroactive compound that appears to reset the brains of drug dependent individuals to a pre-addicted state. Ibogaine has demonstrated effectiveness in treating opioid use disorder and it appears to eliminate the painful symptoms of opioid withdrawal and provides a several month window free of drug cravings. Ibogaine targets multiple receptor sites in the brain when it manages dopamine and serotonin circuits and stimulates new brain cell growth.
More about the company
  1. Stock
  2. Equities
  3. Stock Universal Ibogaine Inc.
  4. Stock Universal Ibogaine Inc. - Toronto S.E.